Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40

Targeted and immune-based therapies are thought to eradicate cancer cells by different mechanisms, and these approaches could possibly complement each other when used in combination. In this study, we report that the in vivo antitumor effects of the c-KIT inhibitor, dasatinib, on the c-KIT mutant P8...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Yan, Liu, Chengwen, Peng, Weiyi, Lizée, Gregory, Overwijk, Willem W., Liu, Yang, Woodman, Scott E., Hwu, Patrick
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Immunobiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3512233/
https://ncbi.nlm.nih.gov/pubmed/22936666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-407163
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars